Read here for ARK Invest's latest 13F updates: portfolio value shifts, top holdings, significant trades, and their ...

On the sell side, ARK offloaded a significant portion of Palantir Technologies Inc (NYSE:NASDAQ: PLTR) stock, divesting ...

Keros Therapeutics shareholder ADAR1 Capital Management said it plans to withhold votes for board members Mary Ann Gray and Alpna Seth.

ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (Nasdaq: ...

Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ: PACB) and 10X Genomics Inc (NASDAQ: TXG ), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 ...

Shares of Vertex Pharmaceuticals Inc. plunged 10.03% to $450.03 Tuesday, on what proved to be an all-around grim trading ...

According to TipRanks.com, Shrader is a 2-star analyst with an average return of 0.2% and a 33.8% success rate. Shrader covers the Healthcare sector, focusing on stocks such as Coya Therapeutics, Inc.

Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

Giovinazzo is a Non-Executive Chairman at XORTX Therapeutics, Inc., an Executive Chairman at Kalgene Pharmaceuticals, Inc. and a Member at Institute of Corporate Directors. He is on the Board of ...

We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a ...

Arcturus Therapeutics (ARCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.